Arcus Biosciences Inc Cash Flow Reinvestment Rate
Arcus Biosciences Inc cash flow reinvestment rate. Arcus Biosciences Inc (RCUS) has a Cash Flow Reinvestment Rate of 1.15x as of September 2024, reinvesting $30.00 Million (capex $1.00 Million plus investments $-29.00 Million) from operating cash flow of $26.00 Million. Explore RCUS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Arcus Biosciences Inc (2020–2022)
Cash flow reinvestment rate of Arcus Biosciences Inc from 2020 to 2022. Historical reinvestment intensity for Arcus Biosciences Inc across 2 annual periods. Explore RCUS capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Arcus Biosciences Inc Cash Flow Reinvestment Rate by Year (2020–2022)
Arcus Biosciences Inc cash flow reinvestment rate by year from 2020 to 2022. Year-by-year capital reinvestment analysis for Arcus Biosciences Inc. For the full cash flow conversion analysis, see how efficiently does Arcus Biosciences Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.96x | $419.00 Million | $438.00 Million | $6.00 Million | ▼ -75.5% |
| 2020 | 3.91x | $434.37 Million | $111.17 Million | $3.06 Million | — |